Effect of Different Subcutaneous Injection Methods on Pain and Satisfaction

February 14, 2025 updated by: Ali Umit Yilmaz, Trakya University

Evaluation of the Effects of Different Methods Used in Subcutaneous Heparin Injections on Pain and Satisfaction

This study; In patients treated with subcutaneous heparin A randomized controlled trial was planned to determine the effect of the injection time and the device called "Palm Stimulator" to reduce the pain felt during injection.

Study Overview

Study Type

Interventional

Enrollment (Actual)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Edirne, Turkey
        • Trakya Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Above 18 years old
  • The one who is literate,
  • No physical, mental disabilities or communication difficulties,
  • Low Molecular Weight Heparin in the treatment plan,
  • No history of allergy,
  • Agreeing to participate in the research,
  • There is no scar tissue, incision or infection in the area to be injected,
  • Patients who will receive a 1-day injection and whose pain score is between 1-10 according to VAS will be admitted.

Exclusion Criteria:

  • Who gave up participating in the research while continuing the research,
  • Using subcutaneous insulin therapy,
  • There is an amputation in the right/left arm area where the study will be performed,
  • There is scar tissue, incision or signs of infection in the area to be injected,
  • Patients who received injections for 1 day and whose pain score is 0 (zero) according to VAS will not be admitted.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: injection time
The application will be done by injecting for 30 seconds and then waiting for 10 seconds and ending the process.
give an injection
Experimental: palm stimulator
By ensuring that the patient grasps the "palm stimulator" equipment in the palm during the injection and squeezes it in the palm throughout the injection. Tactile warning will be given. However, the injection process will last 10 seconds and the process will be terminated after waiting 10 seconds.
give an injection
Experimental: injection time and palm stimulator
Injection will be done for 30 seconds and then waited for 10 seconds and the process will be terminated, and the application will be done using equipment.
give an injection
No Intervention: control group
The injection process will last 10 seconds and the process will be terminated after waiting 10 seconds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scale Patient Identification Form
Time Frame: during injection procedure

Patient Identification Form

It was prepared by researchers by examining the literature on the subject. This form includes 5 questions that include some sociodemographic characteristics of the individual (age, gender, marital status, education status, employment status, etc.) and 8 questions that include characteristics related to health, illness and treatment (presence of chronic disease, body mass index, etc.).

during injection procedure
Visual Scale for pain
Time Frame: during injection procedure
Visual comparison scale for pain The scale consists of a single item, the scale is formed by a 10 cm long line on the horizontal plane. The leftmost side of the line (starting point) is scored as 0 (zero) and the rightmost side (ending point) is scored as 10 (ten) points for the highest possible pain. In order for the patient to score the pain, he/she is asked to mark a point on the line during the injection process. After marking, the distance from the starting point to the marked place is measured and the score is formed. The scale has been proven to be reliable in terms of Turkish as a result of the study conducted by Yaray et al.
during injection procedure
Visual Comparison Scale for Satisfaction
Time Frame: during injection procedure
Visual Comparison Scale for Satisfaction In this scale, scores between 0 and 10 were used to determine satisfaction levels. A score of 0 represented the least satisfaction level, while a score of 10 represented the highest satisfaction level. The Visual Analog Scale was used so that patients could express both their pain and satisfaction levels.
during injection procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2024

Primary Completion (Actual)

September 23, 2024

Study Completion (Actual)

September 23, 2024

Study Registration Dates

First Submitted

February 11, 2025

First Submitted That Met QC Criteria

February 14, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 14, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TUTF-GOBAEK 202313|8

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Acute

Clinical Trials on injection time

Subscribe